About the Vascular Tumors Session
Vascular tumors are abnormal growths that develop in the blood vessels, ranging from benign hemangiomas to malignant angiosarcomas. Research into vascular tumors focuses on understanding their molecular mechanisms, identifying biomarkers for early detection, and developing targeted therapies. Recent studies have uncovered genetic mutations and signaling pathways implicated in their formation, providing potential targets for drug intervention. Advanced imaging techniques such as MRI and CT scans aid in accurate diagnosis and monitoring tumor progression. Immunotherapy and anti-angiogenic drugs show promise in treating aggressive vascular tumors by disrupting blood vessel formation and targeting tumor cells. Collaborative efforts between oncologists, geneticists, and pharmacologists are essential for advancing treatment strategies and improving outcomes for patients with vascular tumors.
Topics Covered in Vascular Tumors
Infantile Hemangioma
Hemangioendothelioma
Angiosarcoma
Vascular Malformations
Beta Blocker Therapy
Anti-Angiogenic Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Vascular Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Vascular Tumors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Vascular Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Vascular Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Vascular Tumors Conference 2027 — FAQs
What is the Vascular Tumors track at CIOC 2027?
The Vascular Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Vascular Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Vascular Tumors sessions?
Cancer researchers and clinicians, educators and students with an interest in Vascular Tumors are all welcome — whether presenting or attending.
Can I present my research in the Vascular Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Vascular Tumors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Vascular Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.